Farther Finance Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
MFPI
CFIM
PRTG
TAM
GWM
MHR
AAG
Farther Finance Advisors's ARKG Position: Q3 2026 in Review
Farther Finance Advisors increased its ARK Genomic Revolution ETF (ARKG) stake by 22% in Q3 2026, buying an estimated $15.6K and bringing the position to 1,914 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #2824.
Farther Finance Advisors first reported a position in ARKG in Q4 2022 and has held it in 16 quarters since. The position peaked at $273K in Q3 2024. 8 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.
- Farther Finance Advisors held 1,914 shares of ARK Genomic Revolution ETF worth $104K as of Q3 2026.
- Farther Finance Advisors bought 348 ARK Genomic Revolution ETF shares in Q3 2026, an estimated $15.6K.
- ARK Genomic Revolution ETF made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #2824 holding.
- Farther Finance Advisors first reported a position in ARK Genomic Revolution ETF in Q4 2022 and has held it in 16 quarters since.
- Farther Finance Advisors's ARK Genomic Revolution ETF position peaked at $273K in Q3 2024.
- 8 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.
Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.